Amarin soars, Lilly slips in afternoon action
April 18, 2011 at 15:58 PM EDT
Amarin shares were soaring in Monday after the company released strong study results for its Omega-3 drug candidate AMR101.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.